NCT05559879 2026-04-15Cabozantinib and Dostarlimab in Recurrent Gynecologic CarcinosarcomaUniversity of Alabama at BirminghamPhase 1/2 Recruiting37 enrolled
NCT06040970 2025-12-02Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial CancerIcahn School of Medicine at Mount SinaiPhase 1/2 Recruiting54 enrolled
NCT04106492 2025-11-14Phase 1/2a Study of SQ3370 in Patients With Advanced Solid TumorsShasqi, Inc.Phase 1/2 Terminated53 enrolled 23 charts
NCT05864144 2025-08-15A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsSensei Biotherapeutics, Inc.Phase 1/2 Active not recruiting98 enrolled
NCT05949632 2025-08-03A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid TumorsIncyte CorporationPhase 1/2 Terminated5 enrolled